Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Cipla
Johnson and Johnson
US Department of Justice
Accenture
AstraZeneca
Dow
Colorcon
Boehringer Ingelheim
Healthtrust

Generated: August 21, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Polymers containing diester units
Abstract:The present invention relates to the process for the preparation of a biodegradable polymer comprising diester units of the formula (III) where R.sup.1 and R.sup.2 each represents a hydrogen atom or a carbon-attached monovalent organic group or R.sup.1 and R.sup.2 together form a carbon-attached divalent organic group; m and n, which may be the same or different, are 0 or 1; and R.sup.3 is a carbon-attached divalent organic grouping.
Inventor(s): Klaveness; Jo (Oslo, NO), Strande; Per (Oslo, NO), Wiggen; Unni Nordby (Rasta, NO)
Assignee: Nycomed Imaging AS (Oslo, NO)
Filing Date:Jun 02, 1995
Application Number:08/458,612
Claims:1. A process for the preparation of a biodegradable polymer comprising diester units of the formula (III) ##STR14## where R.sup.1 and R.sup.2 each represents a hydrogen atom or a carbon-attached monovalent organic group or R.sup.1 and R.sup.2 together form a carbon-attached divalent organic group; m and n, which may be the same or different, are 0 or 1; and R.sup.3 is a carbon-attached divalent organic grouping; which comprises one or more of the following steps:

(A) condensation polymerizing a compound of formula (VI)

where R.sup.8 represents a metal ion and X represents a leaving group reactive therewith, to yield a homopolymer comprising diester units of formula (III) where n is 0;

(B) condensing a compound of formula (XII)

with a compound of formula (XIII)

to yield a homopolymer comprising diester units of formula (III) where m and n are 0;

(C) condensation polymerizing a compound of formula

where R.sup.3A and R.sup.3B each represent carbon-attached divalent groupings and R.sup.9 represents O or a group --NR.sup.4 in which R.sup.4 is selected from the group consisting of a hydrogen atom, an acyl group and a carbon-attached hydrocarbyl group, to yield a homopolymer comprising diester units of formula (III) where R.sup.3 represents a group --R.sup.3B --CO--R.sup.9 --R.sup.3A --;

(D) reacting a compound of formula

with phosgene in the presence of a base, to yield a homopolymer comprising diester units of formula (III) where m and n are 1 and R.sup.3 represents a group --C(R.sup.1 R.sup.2)--;

(E) reacting a compound of formula

and a compound of formula

with phosgene in the presence of a base, to yield a homopolymer comprising diester units of formula (III) where m and n are 1; and

(F) reacting a compound of the formula (XXI)

where R.sup.10 and R.sup.11, optionally together with the groups R.sup.3A and R.sup.3B to which they are attached, each represent reactive functional groupings, with a compound of the formula (XXII)

where R.sup.3C represents a carbon-attached divalent organic grouping and R.sup.12 and R.sup.13 are each selected from the group consisting of functional groupings reactive with said groups R.sup.10 and R.sup.11 or R.sup.10 --R.sup.3A -- and R.sup.11 --R.sup.3B -- and polymerizable groups capable of interaction with said groups R.sup.10 and R.sup.11 or R.sup.10 --R.sup.3A -- and R.sup.11 --R.sup.3B --, to yield a polymer comprising diester units of formula (III).
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Dow
Moodys
Queensland Health
Cantor Fitzgerald
Fish and Richardson
Julphar
Fuji
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot